SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-07-001137
Filing Date
2007-03-16
Accepted
2007-03-16 13:35:17
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w31876e10vk.htm 10-K 1151623
2 EXHIBIT 10.34 w31876exv10w34.htm EX-10.34 83951
3 EXHIBIT 23.1 w31876exv23w1.htm EX-23.1 4277
4 EXHIBIT 23.2 w31876exv23w2.htm EX-23.2 9053
5 EXHIBIT 31.1 w31876exv31w1.htm EX-31.1 8822
6 EXHIBIT 31.2 w31876exv31w2.htm EX-31.2 8868
7 EXHIBIT 32.1 w31876exv32w1.htm EX-32.1 4229
8 EXHIBIT 32.2 w31876exv32w2.htm EX-32.2 4081
  Complete submission text file 0000950133-07-001137.txt   1276279
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 07699167
SIC: 2836 Biological Products, (No Diagnostic Substances)